News headlines about Bioamber (NYSE:BIOA) have trended somewhat positive recently, according to Accern Sentiment. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Bioamber earned a media sentiment score of 0.21 on Accern’s scale. Accern also assigned news articles about the biotechnology company an impact score of 48.4538157730498 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.
These are some of the media stories that may have impacted Accern’s analysis:
- BioAmber Inc. (BIOA) expected to achieve 48.40% earnings growth for this year – Wallstreet Investorplace (wallstreetinvestorplace.com)
- Hair-Raising Facts to Know: BioAmber Inc (NYSE: BIOA) – Alpha Beta Stock (alphabetastock.com)
- BioAmber Inc. (NYSE:BIOA) – An Eye on Data – Nasdaq Journal (nasdaqjournal.com)
- What Analysts Have to Say About Bioamber Inc (BIOA)? – ExpertGazette (expertgazette.com)
- Analysts Sights: Bioamber Inc (BIOA) – ExpertGazette (expertgazette.com)
Shares of Bioamber (NYSE:BIOA) traded down $0.00 during trading hours on Friday, reaching $0.05. The company’s stock had a trading volume of 4,650,000 shares, compared to its average volume of 4,430,000. The company has a market capitalization of $2.54, a price-to-earnings ratio of -0.07 and a beta of 3.29. The company has a current ratio of 1.08, a quick ratio of 0.75 and a debt-to-equity ratio of 0.24. Bioamber has a 1-year low of $0.04 and a 1-year high of $3.36.
ILLEGAL ACTIVITY WARNING: This article was originally published by Ticker Report and is the property of of Ticker Report. If you are viewing this article on another publication, it was illegally stolen and republished in violation of U.S. and international trademark and copyright legislation. The original version of this article can be accessed at https://www.tickerreport.com/banking-finance/3255895/somewhat-positive-news-coverage-somewhat-unlikely-to-impact-bioamber-bioa-share-price.html.
Bioamber Company Profile
BioAmber Inc (BioAmber), formerly DNP Green Technology, Inc, is an industrial biotechnology company, which produces sustainable chemicals. The Company’s technology platform combines industrial biotechnology and chemical catalysis to convert renewable feedstocks into sustainable chemicals that are replacements for petroleum-derived chemicals, which are used in a range of everyday products, including plastics, food additives and personal care products.
Receive News & Ratings for Bioamber Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioamber and related companies with MarketBeat.com's FREE daily email newsletter.